Johansson Yvonne A, Tsevis Theofanis, Nasic Salmir, Gillsjö Catharina, Johansson Linda, Bogdanovic Nenad, Kenne Sarenmalm Elisabeth
Skaraborg Hospital, Skövde, Sweden.
The Research School of Health and Welfare, Aging Research Network-Jönköping (ARN-J), Jönköping University, Jönköping, Sweden.
BMC Geriatr. 2021 Oct 18;21(1):568. doi: 10.1186/s12877-021-02493-3.
Delirium is common in older hospitalized patients. It has serious consequences e.g., poor health outcomes, mortality and increased costs. Despite that, many cases are undetected. Early detection of delirium is important in improving outcomes and use of assessment tools improves detection rates. The 4AT is a brief screening tool for delirium detection, which has not previously been translated into Swedish. The study aim was to evaluate diagnostic accuracy and clinical applicability of a Swedish version of the screening tool 4AT for delirium detection.
This diagnostic test accuracy study used a quantitative and a qualitative approach and evaluated the patients' and the health care professionals' experiences of the tool. Study included 200 patients ≥65 years from a university hospital and a county hospital in two Swedish regions. Medical specialties were geriatric stroke/neurology, geriatric multimorbidity, severe cognitive impairment, orthopaedic, and urology. The translated 4AT was tested against the reference standard DSM-IV-TR criteria, based on the Organic Brain Syndrome scale and patient records. The 4AT was assessed simultaneously and independently by two assessors. Additionally, data was collected through patient record reviews, and questions about applicability to the patients (n = 200) and the assessors (n = 37). Statistical analyses, and qualitative content analyses were conducted.
By reference standard 18% had delirium, and by 4AT 19%. The overall percent agreement was 88%, AUROC 0.808, sensitivity 0.70 (95% CI 0.51-0.84) and specificity 0.92 (95% CI 0.87-0.96). In the ward for severe cognitive impairment (n = 63) the 4AT was less sensitive and less specific. In the other wards (n = 132) sensitivity was 0.77 (95% CI 0.50-0.93), specificity 0.93 (95% CI 0.87-0.97), and AUROC 0.848. Interrater reliability (Kappa) was 0.918, p = < 0.001 (n = 144). The 4AT was well tolerated by patients, easy to use for health care professionals, and took a few minutes to conduct.
The Swedish version of 4AT is an accurate and applicable tool to use in clinical practice for detecting delirium in hospitalized patients across different medical specialities, and to use by different professionals and levels of seniority. To improve patient outcomes, we recommend the 4AT to be incorporated in clinical practice in health care settings in Sweden.
谵妄在老年住院患者中很常见。它会导致严重后果,如健康状况不佳、死亡率上升和成本增加。尽管如此,许多病例仍未被发现。早期发现谵妄对于改善预后很重要,而使用评估工具可提高检出率。4AT是一种用于谵妄检测的简短筛查工具,此前尚未翻译成瑞典语。本研究的目的是评估瑞典语版4AT筛查工具用于谵妄检测的诊断准确性和临床适用性。
这项诊断测试准确性研究采用了定量和定性方法,评估了患者和医护人员对该工具的体验。研究纳入了瑞典两个地区一家大学医院和一家县医院的200名65岁及以上患者。医学专科包括老年中风/神经科、老年多病共存、严重认知障碍、骨科和泌尿外科。根据器质性脑综合征量表和患者记录,将翻译后的4AT与参考标准《精神疾病诊断与统计手册》第四版(DSM-IV-TR)标准进行对照测试。由两名评估人员同时独立评估4AT。此外,通过查阅患者记录以及针对患者(n = 200)和评估人员(n = 37)提出有关适用性的问题来收集数据。进行了统计分析和定性内容分析。
根据参考标准,18%的患者患有谵妄,而根据4AT筛查,这一比例为19%。总体一致性百分比为88%,曲线下面积(AUROC)为0.808,敏感性为0.70(95%置信区间0.51 - 0.84),特异性为0.92(95%置信区间0.87 - 0.96)。在严重认知障碍病房(n = 63),4AT的敏感性和特异性较低。在其他病房(n = 132),敏感性为0.77(95%置信区间0.50 - 0.93),特异性为0.93(95%置信区间0.87 - 0.97),AUROC为0.848。评估者间信度(kappa)为0.918,p = < 0.001(n = 144)。患者对4AT耐受性良好,医护人员易于使用,且只需几分钟即可完成。
瑞典语版4AT是一种准确且适用的工具,可用于临床实践中检测不同医学专科住院患者的谵妄,供不同专业和资历水平的人员使用。为改善患者预后,我们建议在瑞典的医疗机构将4AT纳入临床实践。